A recently proposed plasma-based diagnostic model demonstrated improved sensitivity when compared to traditional biomarkers (CEA and CA19-9), highlighting the potential of circulating immunoglobulin signatures as a non-invasive tool for CRC detection [70]. Here, CEACAM5 is linked to colorectal carcinoma.